PTGS2 and inflammation: The induction of COX-2 and subsequent prostanoid synthesis play pivotal roles in the progression and exacerbation of these inflammatory states, making COX-2 an attractive target for therapeutic interventions aimed at mitigating inflammation-related diseases [9].